Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco Expects Medicare Discount Card Program To Continue Past 2006

Executive Summary

Medco is anticipating that the Medicare-endorsed drug discount card program will be extended beyond Jan. 1, 2006, CEO David Snow told the Goldman Sachs conference in Laguna Niguel, Calif. June 9

You may also be interested in...



Express Scripts Will Stick With Medicare Cards, Despite Slow Uptake

Express Scripts plans to continue its partnership with the National Association of Chain Drug Stores on Medicare-endorsed discount cards into 2005 and beyond, the pharmacy benefit management company said July 29

Express Scripts Will Stick With Medicare Cards, Despite Slow Uptake

Express Scripts plans to continue its partnership with the National Association of Chain Drug Stores on Medicare-endorsed discount cards into 2005 and beyond, the pharmacy benefit management company said July 29

Grady Medicare Card Has 4,000 Enrollees; Bigger Role For 340B In ’05?

Grady Health Systems has enrolled 4,000 low-income Medicare beneficiaries in a drug discount card offering Sec. 340B price discounts

Related Content

UsernamePublicRestriction

Register

PS044159

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel